IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc.

NASDAQ:IDYA

Overview | Financials
Company Name IDEAYA Biosciences, Inc.
Symbol IDYA
Currency USD
Price 25.61
Market Cap 2,213,518,398
Dividend Yield 0%
52-week-range 24.475 - 47.735
Industry Biotechnology
Sector Healthcare
CEO Mr. Yujiro S. Hata
Website https://www.ideayabio.com

An error occurred while fetching data.

About IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors

Related Stocks

Accolade, Inc. logo

Accolade, Inc.

ACCD

3.48 USD

Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc.

INO

1.84 USD

Agenus Inc. logo

Agenus Inc.

AGEN

2.83 USD

MiMedx Group, Inc. logo

MiMedx Group, Inc.

MDXG

9.1 USD

Centessa Pharmaceuticals plc logo

Centessa Pharmaceuticals plc

CNTA

17.16 USD

Leafly Holdings, Inc. logo

Leafly Holdings, Inc.

LFLY

1.62 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

52.91 USD

AxoGen, Inc. logo

AxoGen, Inc.

AXGN

15.64 USD

Financials

Numbers are in millions USD

Numbers are in millions USD